Alexion Sags as Investors Set Sights on Looming Patent Fight

(Bloomberg) -- The wind has been sucked out of the sails at Alexion Pharmaceuticals Inc. after Amgen Inc.’s Otezla deal dashed merger hopes that fueled last week’s rally in the maker of Soliris, le...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.